Verrica Pharmaceuticals Inc.
$1.1M 10,833 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Innovasis Inc
Innovasis Inc reported $1,069,427.90 across General Payments, Research, and Ownership to 368 physicians and teaching hospitals across 368 transactions.
- $1.1M Above-median payer
- All-tracks total
- 368 Above-median volume
- Transactions
- 368 Above-median reach
- Recipients
- +$26.2K
- General Payments vs PY2023
Innovasis Inc reported $1,069,427.90 across all CMS Open Payments tracks (General + Research + Ownership) to 368 physicians and teaching hospitals in Program Year 2024 - ranking #607 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,069,427.90, averaging $2.9K per recipient.
How Innovasis Inc's $1.1M all-tracks total breaks down
Innovasis Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
27/100
Total payments
F
20/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer innovasis-inc Innovasis Inc
$1.1M · #607/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #607
- SHARE 0.0%
- TXN 368
- RCP 368
- CAT 5
- GEN $1.1M
- ΔGEN +$26.2K
- TOP1 9.9%
- PY 2024
Volume peers
Nearest volume peer: Verrica Pharmaceuticals Inc. ($1.1M)
Innovasis Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Innovasis Inc's CMS-reported General Payments increased by $26.2K (+2.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INNOVASIS INCPY2023: INNOVASIS INCPY2024: Innovasis Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,043,229.49
- PY2024
- $1,069,427.90
What the Data Shows for Innovasis Inc
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Innovasis Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
66 transactions worth $407.5K make "Compensation for Services Other Than Consulting" the top general-payment category in the 5-category breakdown below, 38.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Innovasis Inc's largest category was "Compensation for Services Other Than Consulting" at $407.5K - 38.1% of General Payments.
Innovasis Inc reports 5 general-payment categories - the top three are Compensation for Services Other Than Consulting (38.1%), Royalty or License (25.9%), and Consulting Fee (20.1%). The remaining 2 categories make up 15.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Innovasis Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $407.5K | 66 | 38.1% |
| Royalty or License | $277.5K | 41 | 25.9% |
| Consulting Fee | $214.5K | 21 | 20.1% |
| Travel and Lodging | $158.6K | 122 | 14.8% |
| Food and Beverage | $11.4K | 118 | 1.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $396,905.86 (37.1%) of $1,069,427.90 in this company's General Payments records across 103 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Innovasis Inc
The five named recipients with the highest reported General Payments from this company
- 1
Frank Yoo
$105,458.91 across 14 reported transactions
- 2
Paul Tortolani
$92,487.62 across 5 reported transactions
- 3
Anthony Bozzio
$90,927.82 across 6 reported transactions
- 4
Ngoc-Lam Nguyen
$61,390.00 across 4 reported transactions
- 5
Christopher C Harrod
$46,641.51 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Innovasis Inc ranks #607 of 1,925 by total payments (top 32% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,338 of 1,838 by HHI (bottom 27% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Midsouth Orthopedics Inc. : $10.7K total payments, HHI 447
- Acclarent, Inc : $232.0K total payments, HHI 447
- Pinnacle Biologics, Inc : $70.6K total payments, HHI 445
- Gentleman Orthopedic Solutions : $20.0K total payments, HHI 445
- Blue Earth Diagnostics Limited : $324.1K total payments, HHI 444
- Trilliant Surgical LLC. : $844.6K total payments, HHI 443
- Innovasis Inc (this company) : $1.1M total payments, HHI 441
- Avadel CNS Pharmaceuticals, LLC : $1.5M total payments, HHI 441
- Intrinsic Therapeutics : $300.7K total payments, HHI 441
- Braeburn Inc. : $1.2M total payments, HHI 439
- Arthrex, Inc. : $104.3M total payments, HHI 439
- Uoc USA Inc : $460.8K total payments, HHI 437
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Innovasis Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Innovasis Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Innovasis Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Prytime Medical Devices, Inc.
$1.1M 311 recipients
Compare payment profiles
Grifols Therapeutics LLC
$1.1M 1 recipients
Compare payment profiles
Bionova Medical Inc
$1.1M 0 recipients
Compare payment profiles
ZOLL Circulation Inc
$1.1M 485 recipients
Compare payment profiles
Synergy Products LLC
$1.1M 0 recipients
Compare payment profiles
Put this to use
Innovasis Inc ranks #607 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Innovasis Inc sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Innovasis Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.